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Background: Xiaochaihu Decoction (XCHD) prevents hepatocarcinogenesis in association with inhibition of
oxidative stress. However, alkaline phosphatase (ALP) activity, lipopolysaccharides (LPS)-catecholamines (CA)
interactions in gut, liver and brain may play an important role in the status of oxidative stress. This study was to
assess whether XCHD attenuates the vicious circle between oxidative stress and ALP inactivation through LPS-CA
interactions.
Methods: Hepatocellular carcinoma group (HCC) were induced by CCI4 + ethanol; HCC with Liver Depression and
Spleen Deficiency (HCC + LDSD) were induced by squeezing tails (30 min/day), solitary breeding and intermittent
fasting on the basis of HCC; XCHD was administered after 4 weeks of the HCC + LDSD. The degree of tissue injury
were studied using a scoring system, and brain weights were measured. Peroxynitrite (ONOO−), malondialdehyde
(MDA), 4-hydroxy-3-methoxymandelic acid (VMA, CA metabolites), lipopolysaccharide-phosphate (LPS-P), ALP activity
(ALP-A) and Concanavalin A (ConA)-binding rate of ALP (ALP-C) were determined by colorimetric method and lectin
(ConA) affinity precipitation method.
Results: More injuries and ONOO−, MDA, VMA, LPS-P, ALP-C were increased, ALP-A were decreased in the gut, liver
and brain of HCC group, the most in HCC + LDSD group, after treatment with XCHD, all of which were improved. A
positive association found between gut-liver-brain injury and ONOO−, MDA, VMA, LPS-P, ALP-C, between ONOO−,
MDA, VMA, LPS-P and ALP-C in the gut, liver and brain, and a negative association found between gut-liver-brain injury
and ALP-A, between ALP-A and ONOO−, MDA, VMA, LPS-P, ALP-C in the gut, liver and brain.
Conclusions: XCHD can attenuates the vicious circle between the oxidative stress, nitrosative stress, N-glycan
deficiency and inactivation of ALP through LPS-CA interactions in gut, liver and brain.
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The applications of XCHD in treatment of tumors have
attracted more and more attention. XCHD helped to
prevent the development of HCC in patients with cir-
rhosis, particularly in patients without HBs antigen [1],
Shiota et al. found that XCHD (TJ-9) reduced the num-
ber of preneoplastic cells, inhibited the development of
liver tumors, and significantly decreased the formation
of 8-hydroxy-2′-deoxyguanosine (8-OHdG), they con-
cluded that XCHD prevents hepatocarcinogenesis in asso-
ciation with inhibition of 8-OHdG formation [2], but few
literature covers this field of the efficacy of the XCHD by
affecting multiple organ systems.
There is a strong relationship between liver injury and
gut injury by portal system and endogenous gut-derived
bacterial lipopolysaccharides (LPS), which induces pro-
duction of catecholamines (CA) in the gut-liver-brain,
which are involved in the neuroendocrine and immune
effects of LPS, and also contributes to the sensitizing ef-
fect of ethanol preexposure on LPS-induced gut-liver-
brain damage and ultimately, to the LPS-CA interactions
promote hepatocellular carcinoma development [3-9], its
mechanism is still unknown.
Main symptoms for the pattern of LDSD are mental
depression, sentiment, fatigue, reddish or pale tongue,
reduced food intake, fine or fine stringlike pulse.
LDSD has already become common traditional Chin-
ese medicine (TCM) syndrome pattern in clinical, espe-
cially in chronic hepatopathy such as chronic hepatitis,
cirrhosis and hepatocarcinoma. Chronic stress or de-
pression (squeezing tails, solitary breeding and intermit-
tent fasting) is often used to induce LDSD.
We examined whether XCHD attenuates the vicious
circle between the oxidative stress and the ALP inactiva-
tion through LPS-CA interactions in gut, liver and brain
during CCI4 + ethanol-induced mouse HCC with LDSD.
Methods
Ethics
This study was approved by Guangdong Science and
Technology Committee and Guangdong Management
Committee for Medical Experimental Animals.
General procedure
Chinese Kun Ming (KM) mouse were obtained from the
Laboratory Animal Research Center of Guangzhou Uni-
versity of Traditional Chinese Medicine. The animals were
housed in a plastic cage in an air-conditioned room at
20 ± 2°C with a humidity 58% ± 5% in a 12-h light and dark
cycle with free access to standard rat food and tap water.
Animals model
A total of 80 male KM mice (cleaning grade, 30 days of
age, 18-22 g) were used. The KM mouse were divided intofour groups, normal group (10 mice), Hepatocellular car-
cinoma group (HCC,30 mice), were induced as previously
described [10] with some minor modifications by subcuta-
neously injected with 25% CCI4 olive oil solution (5 mL/kg
twice per week) and allowed free access to a 8% ethanol
solution as drinking fluid for 4 weeks, and allowed free
access to a 0.5% CCI4-8% ethanol solution as drinking
fluid for 20 weeks; HCC + LDSD group (HCC + LDSD,
30 mice), on the basis of HCC model, the mouse were
stimulated with the factor of Liver Depression with
Spleen Deficiency (LDSD): squeezing tails (30 min/day)
for 4 weeks, solitary breeding and intermittent fasting
for 20 weeks; HCC + LDSD + XCHD group (XCHD, 30
mice), XCHD was administered by gavage for 8 weeks
after 4 weeks of the HCC + LDSD. We recommend 30
mice/model group, this relatively large number of mice
is recommended to ensure that enough mice for good
statistical analysis, tumor models process often leads to
the incidental death of mice.
Preperation and administration of XCHD
The XCHD consisting of seven herbal medicines (Table 1)
and each crude drug was purchased from Hexiang
Pharmaceutical Co., Ltd., China. The origin of mate-
rials was confirmed and standardized taxonomically by
the Traditional Chinese Medicine Herbal Pharmacy,
Guangzhou University of TCM. A decoction of XCHD
was prepared in our laboratory (Table 1) from a mixture
of chopped crude herbs, extracted in distilled water at
100°C, this mixture was then concentrated to a final con-
centration of 100 crude drug gram per 100 milliliter, was
administered by gavage, 8 g/kg per day for 8 weeks, was
dried out (3.34 g) in hot (100°C) water bath for quantita-
tive assay of saikosaponin a of the major constituents in
XCHD, the procedure is as follows.
Quantitative assay of saikosaponin a of the major
constituents in XCHD [11,12]
Linearity and limits of detection of Saikosaponin a
Standard stock solutions of Saikosaponin a were dis-
solved in 70% methanol containing 0.1 N sulfate acid
and stored below 4°C. Working standard solutions were
prepared by serial dilution of stock solutions with 70%
methanol containing 0.1 N sulfate acid, heated at 100°C
for 3 h, Saikosaponin a were converted completely into
saikosaponin b by mild acid treatment, the absorbance of
Saikosaponin b was detected by UV-spectrophotometer at
252 nm. Calibration curves of Saikosaponin a were calcu-
lated by the absorbance of standard solutions in the con-
centration of 0–200.00 μg /mL.
Quantitative assay of saikosaponin a in XCHD
Freeze-dried XCHD were prepared with 70% methanol
containing 0.1 N sulfate acid, heated at 100°C for 3 h,
Table 1 The composition of XCHD
Latin name Amount (g) Company of purchased Source
Chai Hu (Radix Bupleuri) 20 Hexiang Pharmaceutical Co., Ltd China
Huang Qin (Radix Scutellariae baicalensis) 10 Hexiang Pharmaceutical Co., Ltd China
Dangshen (Codonopsis pilosula) 10 Hexiang Pharmaceutical Co., Ltd China
Ban Xia (Rhizoma Pinelliae Tematae) 10 Hexiang Pharmaceutical Co., Ltd China
Gan Cao (Radix Glycyrhizae Uralensis) 5 Hexiang Pharmaceutical Co., Ltd China
Gan jian (Rhizoma Zingiberis) 5 Hexiang Pharmaceutical Co., Ltd China
Da Zao (Fruc-tus Zizyphi Jujubae) 6 Hexiang Pharmaceutical Co., Ltd China
Total 66
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nin b by mild acid treatment, the absorbance of Saikosapo-
nin b was detected by UV-spectrophotometer at 252 nm.
The amount of Saikosaponin a in XCHD was quanti-
fied using the calibration curves of the above-mentioned
Saikosaponin a.Stability of saikosaponin a in XCHD
The stabilities of Saikosaponin a was examined for
6 days (0, 1, 2, 3, 4 and 5 day respectively) by three
sample solution.Anatomic analysis
Every mouse were autopsied as quickly as possible after
natural death and killed, and photographed, and liver
were embedded in paraffin and stained with hematoxylin
and eosin. The extent of macroscopically apparent in-
flammation ulceration and tissue injury was done un-
blinded by two examiners using a scoring system. This
tissue was weighed, processed and the resulting super-
natant stored at −20°C for the subsequent determination
of ONOO−, MDA, VMA, ALP-A, for the assay of ALP-
C or for the assay of LPS-P.Macroscopic score of gut damage
Intestine macroscopic damage score was calculated as
previously described [13] with some minor modifica-
tions and graded as 0 = no apparent damage, 1 = slight
thickening of intestinal wall, redness, 2 = thickening
and adhesions, no apparent ulcers, 3 = adhesions and
one or more pin-point ulcers, 4 = adhesions and pin-
point ulcers with one or more linear ulcer < 1 cm in
length, 5 = one or more linear ulcer > 1 cm in length.Macroscopic score of fecal loading in the cecum
Fecal loading in the cecum was graded as 0 = no fecal
loading in the cecum, 1 =mild fecal loading in the
cecum, 2 =moderate fecal loading in the cecum, 3 =
marked fecal loading in the cecum.Macroscopic score of liver damage
Iiver macroscopic damage score was graded as 0 = reddish
brown in color, soft in consistency, smooth surface, 1 = the
liver were enlarged, friable, soft in consistency, 2 = hepatic
hyperemia, 3 = an enlarged liver with white focal areas of
necrosis, 4 = an enlarged liver with white multifocal areas
of necrosis, 5 = hepatic steatosis, the liver were soft, yellow,
greasy, enlarged, 6 = the liver is mottled red with bile
stained areas, of normal or increased size, 7 = contains vis-
ible nodules and fibrosis, 8 =micronodular, yellow, fatty,
enlarged, 9 =macronodular, brown, non-greasy, shrunken,
cirrhosis, 10 = explanted liver showing small single gra-
nules bodies, 11 = explanted liver showing large single
granules bodies, 12 = explanted liver showing many
small granules bodies, 13 = explanted liver showing
many large granules bodies.
ALP-A and ALP-C in the tissue
Extracts from tissue were prepared by homogenization in
9 g/L NaCl at 4°C using a DY89-1 tissue homogenizer.
Tissue homogenate was centrifuged at 10000 r/min for
30 min. Clear supernatant were used to determine the
ALP-A and ALP-C by lectin (ConA) affinity precipitation
method, the precipitation procedure was performed as
previously described [14,15]. The clear supernatant were
mixed with 400 μL of an aqueous solution of Con A-
Sepharose 6B (5 g/L in distilled water). The mixture was
incubated for 30 min at 37°C and centrifuged at
2000 r/min for 15 min. Without disturbing the precipi-
tate, we removed the supernate and measured its ALP-
A. ALP-C was calculated by subtracting the corrected
value from the total ALP-A, ALP-A was measured with
β-glycerophosphate as substrate.
The ONOO− levels in the tissue
The tissue were initially deproteinized with Somogyi re-
agent [16] (using 2.0 ml 55 mmol/L NaOH followed by
2.0 ml 75 mmol/L ZnSO4), after centrifugation, aliquots of
supernatant ONOO− concentration was measured from its
absorption at 302 nm by using ε302 = 1670 mol•L
-1•cm-1
[17]. Results were expressed as nmol/L per gram wet tissue.
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Samples were weighed and immediately frozen and
stored at −20°C until analysis within 2 wk. Samples were
subsequently homogenized in buffer and assayed for
MDA content using the thiobarbituric acid (TBA) reac-
tion, as described by Uchiyama and Mihara [18]. with
some minor modifications. Briefly, 0.5 mL of homogen-
ate (10% concentration) was mixed with 3 mL of 0.05 N
HCL. After addition of 1 mL of 0.67% TBA reagent, the
tubes were heated in boiling water for 45 min. The color
was formed with 4 mL of n-butanol and centrifuged.
The color intensity of the butanol layer was estimated by
spectrophotometric absorbance at 535 nm. Results were
expressed as pmol/L per gram wet tissue.LPS-P levels in the tissue
The protocol was performed as previously described
[19,20] with the following modifications. Lipopolysac-
charide was extracted by the hot phenol/water procedure.
The polysaccharide moiety was separated from the lipid A
by hydrolysis of lipopolysaccharide in 10% acetic acid at
100°C for 2.5-4 h. After in separation of lipid A by centri-
fugation at 1300 x g for 15 min, the lipid A was washed
twice with warm water (70-80°C) and once with acetone.
Degraded polysaccharide, obtained from the supernatant
fluid, was purified by centrifugation (10500 × g, 3 h) and
the supernatant was lyophilized, the phosphate content of
LPS was determined with phosphomolybdate-blue spec-
trophotometry. The amount of inorganic phosphate was
quantified using the phosphate standard curve, which was
obtained by using serial dilutions of 1.00 mM KH2PO4
standard solution.VMA levels in the tissue
The protocol was performed as previously described [21]
with the following modifications. VMA is extracted by
ethyl acetate, is oxidised with periodic acid to vanillin,
and the coloured hydrazone formed from the oxidation
product and added 2,4-dinitrophenylhydrazine is mea-
sured in alkali at 460 nm. The amount of VMA was
quantified using the vanillin standard curve, which was
obtained by using serial dilutions of 250 ug/ml vanillin
standard solution.Statistical analysis
Quantitative differences in ONOO−, MDA, VMA, LPS-
P, ALP-A, ALP-C between Normal, HCC, HCC + LDSD
and XCHD were evaluated with the unpaired Student’s
T-test. We evaluated quantitative correlations between
the variables with the spearman rank correlation test.
P values < 0.05 were considered statistically significant.
All analyses were performed using SPSS 17.Results
Linearity and range of detection of saikosaponin a
The linearity of the absorbance at 252 nm (x) versus
concentration (y, μg/mL) curve for Saikosaponin a was
used to calculate the contents of the main components
Saikosaponin a in XCHD. The correlation coefficients(R)
of the calibration curves were 0.9985. The regression
equations were Y = 369.82 × -2.071 for Saikosaponin a.
These results showed that the calibration curve was a
good linearity.
Stability of saikosaponin a in XCHD
The stability test of Saikosaponin a was evaluated using
the sample solution for 6 days. In Table 2, sample solu-
tion retained a content of 76.92-100.88% as compared
with the initial content at 0 day. The RSD values of con-
tents about saikosaponin a compounds in sample solu-
tion were with in 15.52%.
Histological and anatomic analysis
During chemical induction of hepatic cancer by CCI4 +
ethanol, Histological examination of liver sections by H&E
staining showed that the induction of hepatic cancer in-
volves four stages: stage 1, hepatic steatosis occurred at 5
to 8 weeks during hepatic carcinoma induction; stage 2,
hepatic cirrhosis occurred at 9 to 12 weeks during hep-
atic carcinoma induction; stage 3, precancerous Lesion
of Liver occurred at 13 to 16 weeks during hepatic car-
cinoma induction; stage 4, hepatic carcinoma occurred
at 17 to 24 weeks during hepatic carcinoma induction
(Figure 1).
HCC group were significantly more deep red color of
liver, the surface of the liver is granular and nodular, a
more disordered structure of hepatic lobule, the hepatic
cell nuclear anachromasis with nuclear atypia in the
H&E stained section. HCC + LDSD group were signifi-
cantly more dark red color of liver, the surface of the
liver is granular and nodular, a more disordered struc-
ture of hepatic lobule, the hepatic cell nuclear anachro-
masis with nuclear atypia in the H&E stained section.
Significantly more injuries in small intestine, cecum,
liver(mainly hyperplasia) of HCC, only a slight non-
significant reduction was observed in brain weights,
compared with normal group, the most in HCC + LDSD
group, compared with HCC group, after treatment with
XCHD, all of which were improved, compared with
HCC + LDSD group. The other organs do not show ob-
vious macroscopic damage (Table 3).
Effects of XCHD on MDA, ONOO−, VMA, LPS-P, ALP-A,
ALP-C in the gut, liver and brain
ONOO−, MDA, VMA, LPS-P, ALP-C were increased,
ALP-A were decreased in the gut, liver and brain of HCC
group, compared with normal group, the most in HCC +
Table 2 Stability of saikosaponin a compounds for 6 days XCHD (n=3)

























Saikosaponin 0.14±0.03 2.19 0.14±0.02 1.38 0.14±0.01 7.85 0.12±0.08 6.77 0.12±0.09 7.99 0.11±0.16 15.52
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with XCHD, all of which were improved, compared with
HCC+ LDSD group (Table 4).
The correlation coefficient between gut injuries, liver
injuries, brain injuries, MDA, ONOO−, VMA, LPS-P, ALP,
ALP-C
Correlative analysis showed that there was a positive as-
sociation between gut-liver-brain injury and ONOO−,
MDA, VMA, LPS-P, ALP-C, between ONOO−, MDA,
VMA, LPS-P and ALP-C in the gut, liver and brain,
there was a negative association between gut-liver-brain
injury and ALP-A, between ALP-A and ONOO−, MDA,
VMA, LPS-P, ALP-C in the gut, liver and brain (Tables 5,
6, 7 and 8).Figure 1 CCI4 + ethanol–induced hepatocellular carcinoma (HCC) Chin
autopsied after natural death and killed. Histological examination of live
cancer involves four stages: stage 1, hepatic steatosis occurred at 5 to 8 we
hepatic precancerous lesion occurred at 13 to 16 weeks; stage 4, hepatic c
representative of at least two observations.Discussion
In our present study, more injuries and ONOO−, MDA,
VMA, LPS-P, ALP-C were increased, ALP-A were de-
creased in the gut, liver and brain of HCC group, com-
pared with normal group, the most in HCC with Liver
Depression and Spleen Deficiency(LDSD) group, com-
pared with HCC group, after treatment with XCHD, all
of which were improved, compared with HCC + LDSD
group (Tables 3 and 4). A positive association found be-
tween gut-liver-brain injury and ONOO−, MDA, VMA,
LPS-P, ALP-C, between ONOO−, MDA, VMA, LPS-P,
ALP-C, and a negative association found between gut-
liver-brain injury and ALP-A, between ALP-A and
ONOO−, MDA, VMA, LPS-P, ALP-C in the gut, liver
and brain (Tables 5, 6, 7 and 8).ese Kun Ming (KM) mouse were treated with CCI4 + ethanol and
r sections by H&E staining showed that the induction of hepatic
eks; stage 2: hepatic cirrhosis occurred at 9 to 12 weeks; stage 3,
arcinoma occurred at 17 to 24 weeks. Photomacrographs are liver
Table 3 Effect of XCHD on macrospic gut-liver injury and brain weights
Groups Dose (gkg-1) n Intestine
injury score
Cecum injury score Fecal loading in
the cecum (score)
Colore injury score Liver injury score Brain
weights (g)
Normal - 6 0.5±0.55 0.67±0.52 0.67±0.52 0.33±0.52 0.5±0.55 0.44±0.04
HCC - 13 1.77±0.73b 1.62±0.51b 1.15±0.69 0.46±0.52 9.15±2.08b 0.43±0.04
HCC+LDSD - 9 2.33±0.50c 2.33±0.71c 1.44±0.73 0.56±0.53 10.67±1.80c 0.39±0.06
XCHD 8 14 1.57±0.52f 1.50±0.52f 1.33±0.52 0.43±0.51 8.21±2.08f 0.43±0.05
b<0.01 Compare with normal; cP <0.05 Compare with HCC; f<0.01 Compare with HCC+ LDSD.
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http://www.biomedcentral.com/1472-6882/13/375Yu LX et al. [7] found endotoxin accumulation prevents
carcinogen-induced apoptosis and promotes liver tumori-
genesis. Zhou L et al. [22] and Tang CH et al. [23] found
oxidative stress-induced 1, N6-ethenodeoxyadenosine
adduct formation and uncontrolled nitrosative stressTable 4 Effects of XCHD on MDA, ONOO-, VMA, LPS-P, ALP-A































aP <0.05, bP<0.01 Compare with normal; cP <0.05, dP <0.01 Compare with HCC; eP <contributes to hepatocarcinogenesis. Xiang Q et al. [24]
found LPS-induced hepatotoxicity possibly by cytotoxic ef-
fects of oxygen free radicals, NO and cytokines, carnosic
acid successfully and dose dependently attenuates the
effects of LPS.von Montfort C et al. [5] found theand ALP-C in the gut, liver and brain

























0.05, fP <0.01 Compare with HCC+LDSA.
Table 5 The correlation coefficient between gut injury, liver injury, brain injury, MDA, ONOO, CMA, LPS-P, ALP-A
and ALP-C in the gut
n ALP-A ALP-C MDA ONOO LPS-P VMA
ALP-A 24 −0.68b −0.79b −0.78b −0.71b −0.71b
ALP-C 24 0.49b 0.57b 0.63b 0.59b
MDA 24 0.94b 0.73b 0.92b
ONOO- 24 0.70b 0.91b
LPS-P 24 0.79b
Intestine 24 −0.87b 0.56b 0.78b 0.80b 0.64b 0.69b
Cecum injury 24 −0.60b 0.66b 0.53b 0.63b 0.63b 0.66b
Fecal loading in the cecum 24 −0.60b 0.66b 0.53b 0.63b 0.63b 0.26
Colorectal injury 24 0.03 0.20 0.01 0.02 0.25 0.17
Liver injury 24 −0.80b 0.68b 0.68b 0.73b 0.54b 0.63b
Brain weights 24 0.46a −0.42a −0.52b −0.41a −0.53b 0.55b
aP<0.05, bP<0.01, test of significance of correlation coefficient.
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hances LPS-induced liver damage. Schäper J et al. [25]
found Regional sympathetic blockade significantly at-
tenuated the endotoxin-induced increases in gut epithe-
lial permeability, expression of nitric oxide synthase,
macrophage infiltration, and lipid peroxidation. Adham
KG et al. [26] found lipopolysaccharide stimulated the
biosynthesis of norepinephrine and dopamine in all
brain regions, was completely abolished by pretreat-
ment with indomethacin.
The toxic moiety of Lipopolysaccharide (LPS) is the
well-preserved lipid A part. Lipid A contains two phos-
phate groups attached to diglucosamine, which are crucial
for the many biological activities of LPS [27]. Radiodetoxi-
fied lipopolysaccharide fails to activate the hypophyseal-
pituitary-adrenal axis [28] and alkaline Phosphatase (ALP)
was able to dephosphorylate LPS and prevents inflamma-
tion [29].Table 6 The correlation coefficient between gut injury, liver i







Intestine 24 −0.80b 0.80b
Cecum injury 24 −0.65b 0.51b
Fecal loading in the cecum 24 −0.33 0.32
Colorectal injury 24 −0.09 −0.32
Liver injury 24 −0.94b 0.87b
Brain weights 24 0.53b −0.39
aP<0.05, bP<0.01, test of significance of correlation coefficient.ALP are important defense factor in protecting the
gut-liver-brain multiple organ against bacterial infection
[30-32]. Halling Linder C et al. [33] found significantly
different catalytic properties among the bone ALP iso-
forms due to structural differences in N-glycosylation.
The changes in protein N-glycosylation play an import-
ant role in the pathogenesis and progression of various
liver diseases [34]. Cottalasso D et al. [35] found ethanol
administration induces a marked decrease of dolichyl
phosphate (a glycosyl sugar carrier for N-glycosylation
of proteins) in rat liver microsomes and Golgi apparatus.
Yasuda J et al. [36] found ROS result in the cleavage of
oligosaccharides of glycoproteins including transferrin
may contribute the development of acute hepatitis.
We had previously found [14] that ConA, PSA, PNA,
and LCA binding rate of serum amylase were signifi-
cantly higher in HCC and hepatocirrhosis patients than
hepatitis patients and normal controls. PSA and LCAnjury, brain injury, MDA, ONOO-, VMA, LPS-P, ALP-A and
MDA ONOO LPS-P VMA
b −0.42a −0.68b −0.75b −0.83b




0.50b 0.70b 0.63b 0.73b
0.30 0.60b 0.34 0.76
0.24 0.17 0.40a 0.36a
0.02 0.18 −0.11 0.17
0.43a 0.55b 0.73b 0.75b
a −0.49b −0.51b −0.22 −0.60b
Table 7 The correlation coefficient gut injury, liver injury, brain injury, MDA, ONOO-, VMA, LPS-P, ALP-A and ALP-C
in the brain
n ALP-A ALP-C MDA ONOO LPS-P VMA
ALP-A 24 0.30 −0.25 −0.49b −0.42a −0.52b
ALP-C 24 0.57 0.51b 0.51b 0.25
MDA 24 0.76b 0.71b 0.46a
ONOO- 24 0.84b 0.66b
LPS-P 24 0.63b
Intestine 24 −0.26 0.39a 0.73b 0.80b 0.61b 0.39
Cecum injury 24 −0.36 0.38a 0.50b 0.69b 0.71b 0.66b
Fecal loading in the Cecum 24 −0.09 0.44a −0.05 0.12 0.23 −0.01
Colorectal injury 24 −0.09 0.20 −0.05 0.12 0.23 −0.01
Liver injury 24 −0.17 0.53b 0.76b 0.65b 0.55b 0.50b
Brain weights 24 0.05 −0.63b −0.39a −0.50b −0.50b −0.19
aP<0.05, bP<0.01, test of significance of correlation coeficient.
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http://www.biomedcentral.com/1472-6882/13/375binding rate of serum amylase were significantly higher
in HCC + LDSD patients than those with liver and kid-
ney Yin deficiency. HCC + LDSD patients had higher
ConA binding rate of serum amylase compared with
those with QI and blood stasis. A positive correlationTable 8 The correlation coefficient between MDA, ONOO-,














24 0.51b 0.60b 0.44a 0.42a 0.40a
24 0.80b 0.63b −0.63b 0.60b





24 0.62b 0.84b 0.86b 0.84b −0.73b 0.69b
24 0.55b 0.81b 0.90b 0.84b −0.80b 0.68b
24 0.60b 0.86b 0.93b 0.76b −0.73b 0.60b
24 0.41a 0.74b 0.69b 0.59b −0.64b 0.67b
24 −0.56b −0.72b −0.76b −0.71b 0.82b −0.89b
24 0.29 0.63b 0.64b 0.56b −0.76b 0.66b
Brain
24 0.55b 0.66b 0.80b 0.74b −0.83b 0.69b
24 0.61b 0.84b 0.95b 0.73b −0.74b 0.62b
24 0.20 0.60b 0.67b 0.54b −0.53b 0.43
24 0.52b 0.89b 0.85b 0.64b −0.71b 0.58b
24 −0.29 −0.47a −0.34 −0.53b 0.21 −0.41a
24 0.35a 0.36a 0.68b 0.35a −0.62b 0.28
aP<0.05, bP<0.01, test of significance of correlation coeficient.was found between PSA, LCA, and PNA binding rate of
serum amylase and MDA.
Conclusions
Above all these observations suggest that there was a
significant increase in gut-liver-brain injury of CCI4 +
ethanol-induced mouse HCC, it is associated with the
vicious circle between the oxidative stress, nitrosative
stress and N-glycan deficiency and inactivation of ALP
in gut, liver and brain through LPS-CA interactions.
LDSD significantly increased gut-liver-brain injury in
CCI4 + ethanol-induced mouse HCC, it's maily because
LDSD can significantly aggravate the vicious circle be-
tween the oxidative stress, nitrosative stress and N-
glycan deficiency and inactivation of ALP in gut, liver
and brain through LPS-CA interactions.
XCHD significantly decreased gut-liver-brain injury in
CCI4 + ethanol-induced mouse HCC, it's maily because
XCHD can significantly attenuate the vicious circle be-
tween the oxidative stress, nitrosative stress and N- gly-
can deficiency and inactivation of ALP in gut, liver and
brain through LPS-CA interactions, by increased N-
glycan and activation of ALP, decreased LPS toxicity,
oxidative stress, nitrosative stress, CA (VMA), ultimately
to improved the gut, liver and brain injury and the dys-
function of gut-liver-brain interactions.
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